95
Views
1
CrossRef citations to date
0
Altmetric
Original Research

Lower Patient Anxiety and Unchanged Levels of Adherence to Hemato-Oncologic Treatment in Response to New Measures to Reduce Hospital Exposure Risk to COVID-19

, , , , , , , , & ORCID Icon show all
Pages 945-952 | Published online: 10 May 2021

References

  • Guan WJ, Ni ZY, Hu Y, et al. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med. 2020;382(18):1708–1720. doi:10.1056/NEJMoa2002032
  • Birenbaum-Carmeli D, Chassida J. Covid-19 in Israel: socio-demographic characteristics of first wave morbidity in Jewish and Arab communities. Int J Equity Health. 2020;19(1):153. doi:10.1186/s12939-020-01269-2
  • Chen T, Wu D, Chen H, et al. Clinical characteristics of 113 deceased patients with coronavirus disease 2019: retrospective study. BMJ. 2020;368:m1091. doi:10.1136/bmj.m1091
  • Williamson EJ, Walker AJ, Bhaskaran K, et al. Factors associated with COVID-19-related death using OpenSAFELY. Nature. 2020;584(7821):430–436. doi:10.1038/s41586-020-2521-4
  • Wu Z, McGoogan JM. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) Outbreak in China: summary of a Report of 72314 cases from the Chinese center for disease control and prevention. JAMA. 2020;323(13):1239–1242. doi:10.1001/jama.2020.2648
  • Isidori A, de Leval L, Gergis U, Musto P, Porcu P. Management of patients with hematologic malignancies during the COVID-19 pandemic: practical considerations and lessons to be learned. Front Oncol. 2020;10:1439. doi:10.3389/fonc.2020.01439
  • Lee LYW, Cazier JB, Starkey T, et al. COVID-19 prevalence and mortality in patients with cancer and the effect of primary tumour subtype and patient demographics: a prospective cohort study. Lancet Oncol. 2020;21(10):1309–1316. doi:10.1016/S1470-2045(20)30442-3
  • Mato AR, Roeker LE, Lamanna N, et al. Outcomes of COVID-19 in patients with CLL: a multicenter international experience. Blood. 2020;136(10):1134–1143. doi:10.1182/blood.2020006965
  • Passamonti F, Cattaneo C, Arcaini L, et al. Clinical characteristics and risk factors associated with COVID-19 severity in patients with haematological malignancies in Italy: a retrospective, multicentre, cohort study. Lancet Haematol. 2020;7(10):e737–e45. doi:10.1016/S2352-3026(20)30251-9
  • Kurniawan A, Halim D, Sutandyo N. Multiple myeloma management in COVID-19 Era. Asian J Oncol. 2021;7(01):01–7. doi:10.1055/s-0040-1716813
  • Karacin C, Bilgetekin I, F BB, Oksuzoglu OB. How does COVID-19 fear and anxiety affect chemotherapy adherence in patients with cancer. Future Oncol. 2020;16(29):2283–2293. doi:10.2217/fon-2020-0592
  • Pareek P, Vishnoi JR, Kombathula SH, Vyas RK, Misra S. Teleoncology: the Youngest Pillar of Oncology. JCO Glob Oncol. 2020;6:1455–1460. doi:10.1200/GO.20.00295
  • Li Q, Chen L, Li Q, et al. Cancer increases risk of in-hospital death from COVID-19 in persons <65 years and those not in complete remission. Leukemia. 2020;34(9):2384–2391. doi:10.1038/s41375-020-0986-7
  • Santosh KC. COVID-19 prediction models and unexploited data. J Med Syst. 2020;44(9):170. doi:10.1007/s10916-020-01645-z
  • Maringe C, Spicer J, Morris M, et al. The impact of the COVID-19 pandemic on cancer deaths due to delays in diagnosis in England, UK: a national, population-based, modelling study. Lancet Oncol. 2020;21(8):1023–1034. doi:10.1016/S1470-2045(20)30388-0
  • Jazieh AR, Akbulut H, Curigliano G, et al. Impact of the COVID-19 pandemic on cancer care: a Global Collaborative Study. JCO Glob Oncol. 2020;6:1428–1438. doi:10.1200/GO.20.00351
  • Onesti CE, Rugo HS, Generali D, et al. Oncological care organisation during COVID-19 outbreak. ESMO Open. 2020;5:4. doi:10.1136/esmoopen-2020-000853
  • Ozdin S, Bayrak ozdin S. Levels and predictors of anxiety, depression and health anxiety during COVID-19 pandemic in Turkish society: the importance of gender. Int J Soc Psychiatry. 2020;66(5):504–511. doi:10.1177/0020764020927051
  • Wang Y, Di Y, Ye J, Wei W. Study on the public psychological states and its related factors during the outbreak of coronavirus disease 2019 (COVID-19) in some regions of China. Psychol Health Med. 2020;1–10.
  • Hamilton E, Van Veldhuizen E, Brown A, Brennan S, Sabesan S. Telehealth in radiation oncology at the Townsville Cancer Centre: service evaluation and patient satisfaction. Clin Transl Radiat Oncol. 2019;15:20–25. doi:10.1016/j.ctro.2018.11.005
  • Young JD, Badowski ME. Telehealth: increasing access to high quality care by expanding the role of technology in correctional medicine. J Clin Med. 2017;6(2):20. doi:10.3390/jcm6020020
  • Ramaswamy A, Yu M, Drangsholt S, et al. Patient satisfaction with telemedicine during the COVID-19 Pandemic: retrospective Cohort Study. J Med Internet Res. 2020;22(9):e20786. doi:10.2196/20786
  • Ferguson JM, Jacobs J, Yefimova M, Greene L, Heyworth L, Zulman DM. Virtual care expansion in the veterans health administration during the COVID-19 Pandemic: clinical services and patient characteristics associated with utilization. J Am Med Inform Assoc. 2020.
  • Tam S, Wu VF, Williams AM, et al. Disparities in the uptake of telemedicine during the COVID-19 surge in a multidisciplinary head and neck cancer population by patient demographic characteristics and socioeconomic status. JAMA Otolaryngol Head Neck Surg. 2020. doi:10.1001/jamaoto.2019.3751
  • Cheung KL, Ten KPM, Smit C, de Vries H, Pieterse ME. The impact of non-response bias due to sampling in public health studies: a comparison of voluntary versus mandatory recruitment in a Dutch national survey on adolescent health. BMC Public Health. 2017;17(1):276. doi:10.1186/s12889-017-4189-8
  • Mazor KM, Clauser BE, Field T, Yood RA, Gurwitz JH. A demonstration of the impact of response bias on the results of patient satisfaction surveys. Health Serv Res. 2002;37(5):1403–1417. doi:10.1111/1475-6773.11194
  • Puts MTE, Tu HA, Tourangeau A, et al. Factors influencing adherence to cancer treatment in older adults with cancer: a systematic review. Ann Oncol. 2014;25(3):564–577.